Synthesis and antitubercular activity of 3-aryl substituted-2-(1H(2H) benzotriazol-1(2)-yl)acrylonitriles

被引:100
作者
Sanna, P [1 ]
Carta, A [1 ]
Nikookar, MER [1 ]
机构
[1] Dipartimento Farmaco Chim Tossicol, I-07100 Sassari, Italy
关键词
antimycobacterial activity; 3-aryl substituted-2-(1H(2H)-benzotriazol-1(2)-yl)acrylonitriles; Knoevenagel condensation;
D O I
10.1016/S0223-5234(00)00144-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 22 3-aryl substituted-2-(1H(2H)-benzotriazol-1(2)-yl)acrylonitriles was synthesized for a preliminary in vitro evaluation of antitubercular activity according to an international program with the Tuberculosis Antimicrobial Acquisition & Coordinating Facility (TAACF). This work reports the synthetic approach and analytical and spectroscopic characterization (UV, IR, H-1- and C-13-NMR) of all compounds synthesized. Several compounds showed an interesting activity in the preliminary screening with a percent growth inhibition of the virulent Mycobacterium tuberculosis between 40 and 99% at the concentration of 12.5 mu g/mL. The most effective derivatives E-5a and E-5e were also tested against M. avium in vitro. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:535 / 543
页数:9
相关论文
共 25 条
[1]  
Ambrosoli G, 1970, Boll Chim Farm, V109, P251
[2]  
BILLO NE, 1998, MYCOBACTERIA 2 CHEMO, P1
[3]  
BUKOWSKI L, 1986, POL J PHARMACOL PHAR, V38, P91
[4]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[5]  
Danan A, 1997, FARMACO, V52, P227
[6]  
EVA S, 1993, Patent No. 275212
[7]  
GRINEV AN, 1977, KHIM FARM ZH+, V11, P78
[8]   SURVEY OF C-13-H SPLITTINGS IN ALKENES [J].
KINGSBURY, CA ;
DRANEY, D ;
SOPCHIK, A ;
RISSLER, W ;
DURHAM, D .
JOURNAL OF ORGANIC CHEMISTRY, 1976, 41 (24) :3863-3868
[9]   THE GLOBAL TUBERCULOSIS SITUATION AND THE NEW CONTROL STRATEGY OF THE WORLD-HEALTH-ORGANIZATION [J].
KOCHI, A .
TUBERCLE, 1991, 72 (01) :1-6
[10]   Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice? [J].
Lounis, N ;
Ji, BH ;
TruffotPernot, C ;
Grosset, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :607-610